Description

Budesonide 3 mg cap. release.

Common uses

Mild to moderate Crohn's disease affecting the ileum or ascending colon.

Contraindications

Bacterial, fungal or viral infections. Children not recommended.

Dosage

Adults: 3 caps once daily in the morning before breakfast for up to 8 weeks.

Entocort is an oral steroid recently approved for use in the treatment of Crohn's disease. The advantage of this preparation over other oral steroids is its formulation. The capsule delays the release of the steroid until it reaches the small intestine. This allows the use of a smaller dose than otherwise if it had to act systematically instead of locally. In addition the lower dose significantly reduces the incidence of side effects.